pSivida Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis
May 19, 2015 at 07:35 AM EDT
pSivida Corp. (NASDAQ: PSDV); (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye ...